Yechun Xu

机构：Nanjing University of Chinese Medicine, Chinese Academy of Sciences, Shanghai Institute of Materia Medica, Institute for Advanced Study, University of Chinese Academy of Sciences, State Key Laboratory of Drug Research · ORCID：0000-0002-1581-6155

发表论文 184 篇 · 总被引 11405 次 · h-index 47

代表论文

• PPIA dictates NRF2 stability to promote lung cancer progression (2024 · Nature Communications · 被引 48)
• Covalent DNA-Encoded Library Workflow Drives Discovery of SARS-CoV-2 Nonstructural Protein Inhibitors (2024 · Journal of the American Chemical Society · 被引 27)
• De novo design of protein condensation inhibitors by targeting an allosteric site of cGAS (2025 · Nature Communications · 被引 21)
• Structure-based design of potent and selective inhibitors targeting RIPK3 for eliminating on-target toxicity in vitro (2025 · Nature Communications · 被引 13)
• Dynamic Cap‐Mediated Substrate Access and Potent Inhibitor Design of Monkeypox Virus I7L Protease (2025 · Advanced Science · 被引 10)
• Development of a self-assembled micelles based on cryptotanshinone and glycyrrhizic acid: An efficient strategy for acne treatment (2025 · International Journal of Pharmaceutics · 被引 10)